GALWAY, Ireland--(BUSINESS WIRE)--Aerogen, the global leader in aerosol drug delivery, today announced details of a broad collaborative effort to support pharmaceutical companies from around the world ...
Aerogen, a specialty pharmaceutical company, develops products based on its OnQ (TM) Aerosol Generator technology to improve the treatment of respiratory disorders in the acute care setting. Aerogen ...
U.S. Nebulizer Market · GlobeNewswire Inc. Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "United States Nebulizer Market Report by Type, Modality, Applications, End Use, States and Company Analysis, ...
GALWAY, Ireland — Following months of collaborative development work, Aerogen ® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) have announced a development and commercial ...
> Oramed ($ORMP) secured a patent in Australia and its home country of Israel for a core concept of its insulin oral delivery. This adds to a list of countries that ...
Aerogen Inc announced the results of its Phase II clinical study using the Aerodose albuterol inhaler at The American College of Chest Physicians conference in Philadelphia. The results of the study ...
Trump administration officials predicted that a sharp increase in gasoline prices resulting from the Iran war would last only weeks. Reuters, the news and media division of Thomson Reuters, is the ...
Aerogen is the world leader in acute care aerosol drug delivery, having treated 12 million patients in 75 countries through its pioneering aerosol technology. A recipient of several international ...
Synairgen's SNG001 among the many potential treatments and vaccines to be delivered via Aerogen's aerosol drug delivery system Adds to the thousands of COVID-19 patients already safely and effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results